Temsirolimus in metastatic renal cell carcinoma.
Négrier
S
S
Centre Léon Bérard, Medical Oncology, 28 Rue Laennec, 69008 Lyon, France. Electronic address: negrier@lyon.fnclcc.fr.
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D020123:Sirolimus / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; C401859:temsirolimus; D020123:Sirolimus